Park Avenue Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.47M Buy
48,906
+327
+0.7% +$50.1K 0.06% 245
2025
Q4
$6.7M Sell
48,579
-4,313
-8% -$565K 0.06% 249
2025
Q3
$6.78M Sell
52,892
-2,427
-4% -$296K 0.05% 258
2025
Q2
$6.69M Buy
55,319
+8,811
+19% +$993K 0.06% 228
2025
Q1
$5.18M Buy
46,508
+3,381
+8% +$360K 0.06% 197
2024
Q4
$4.2M Buy
43,127
+10,276
+31% +$1.1M 0.04% 283
2024
Q3
$3.78M Sell
32,851
-1,631
-5% -$185K 0.04% 274
2024
Q2
$3.67M Buy
34,482
+6,862
+25% +$689K 0.04% 265
2024
Q1
$2.67M Sell
27,620
-4,502
-14% -$462K 0.03% 322
2023
Q4
$3.24M Buy
32,122
+2,039
+7% +$197K 0.04% 249
2023
Q3
$3.06M Buy
30,083
+1,442
+5% +$146K 0.05% 236
2023
Q2
$2.89M Buy
28,641
+5,016
+21% +$502K 0.05% 239
2023
Q1
$2.17M Sell
23,625
-219
-0.9% -$19.1K 0.04% 279
2022
Q4
$2.16M Buy
23,844
+3,091
+15% +$260K 0.04% 286
2022
Q3
$1.58M Buy
20,753
+1,409
+7% +$117K 0.03% 316
2022
Q2
$1.64M Buy
19,344
+2,802
+17% +$246K 0.03% 309
2022
Q1
$1.45M Buy
16,542
+2,388
+17% +$207K 0.03% 357
2021
Q4
$1.24M Sell
14,154
-1,544
-10% -$128K 0.02% 391
2021
Q3
$1.28M Buy
15,698
+814
+5% +$73.2K 0.03% 338
2021
Q2
$1.36M Buy
14,884
+398
+3% +$35.4K 0.03% 307
2021
Q1
$1.24M Buy
14,486
+147
+1% +$13.2K 0.03% 290
2020
Q4
$1.35M Buy
14,339
+516
+4% +$45.1K 0.04% 223
2020
Q3
$1.2M Buy
13,823
+684
+5% +$59.3K 0.04% 201
2020
Q2
$1.15M Buy
13,139
+3,529
+37% +$305K 0.04% 172
2020
Q1
$792K Buy
9,610
+454
+5% +$40.5K 0.07% 93
2019
Q4
$867K Buy
9,156
+1,223
+15% +$110K 0.04% 202
2019
Q3
$689K Buy
7,933
+1,493
+23% +$134K 0.03% 204
2019
Q2
$588K Buy
6,440
+652
+11% +$55.2K 0.07% 108
2019
Q1
$496K Buy
5,788
+1,946
+51% +$156K 0.03% 224
2018
Q4
$302K Buy
3,842
+664
+21% +$51.7K 0.05% 118
2018
Q3
$246K Sell
3,178
-410
-11% -$30.3K 0.04% 151
2018
Q2
$240K Buy
+3,588
New +$248K 0.04% 137

Other funds holding NVS